Trial Profile
Multi-center, Single Arm, Open-label, Phase IV Clinical Trial to Evaluate the Safety and Efficacy of MEDITOXIN in Children With Cerebral Palsy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Mar 2019
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Cerebral palsy
- Focus Therapeutic Use
- Sponsors Medytox
- 25 Mar 2019 Status changed from recruiting to completed.
- 09 Dec 2014 New trial record